克西拉和阿片类药物的同时使用增强了平面动物的刻板印象运动
Amy D Stringer1, Scott M Rawls1,2
1Center for Substance Abuse Research.
Behavioural pharmacology
|October 14, 2025
概括
兽医药物西拉和吗啡一起增加了平面动物的刻板印象运动. 这项研究揭示了在简单的神经系统模型中,克西拉-阿片类药物相互作用及其行为影响.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 行为科学 行为科学
背景情况:
- 克西拉是一种兽用α2-上腺素受体激动剂,越来越多地被滥用作为非法阿片类药物 adulterant.
- 有限的临床前研究存在于西拉的药理作用及其对阿片类药物相关行为的影响.
- 平面生物是具有中央神经系统的简单生物,表现出类似哺乳动物的行为和神经递质,使他们成为研究药物效应的模型.
研究的目的:
- 为了研究单独和与吗啡结合的西拉对平面动物的行为影响.
- 为了比较克西拉与克洛尼丁的效果,FDA批准的α2-上腺受体激动剂.
- 分析克西拉-阿片类药物相互作用及其对刻板印象运动和运动性的影响.
主要方法:
- 普拉纳人接触到不同度的西拉,克洛尼丁和吗啡.
- 记录了行为反应,包括刻板印象的动作 (C字形,抽机,,摇头,摇头) 和运动.
- 测试了吗啡与西拉或克隆尼丁的组合,以评估协同作用或对抗作用.
主要成果:
- 克西拉和克洛尼丁都在度≥100μM时增加了刻板的运动和减少了运动能力,克西拉显示出更大的最大效应,而克洛尼丁更强效.
- 仅仅是吗啡也引起了刻板印象和减少了运动能力.
- 在吗啡,西拉和克洛尼丁的存在下,诱导的刻板印象进一步增强,特别是头. 吗啡特异性增强了C字形和螺栓塞用克西拉,但不是克洛尼丁.
结论:
- 克西拉和克洛尼丁诱导了刻板印象的运动,并降低了平面动物的运动能力,模仿了阿片类药物的某些作用.
- 在平面生物中发现了西拉与阿片类药物的相互作用,这表明吗啡增强了西拉诱导的刻板印象.
- 克西拉与克洛尼丁在与吗啡结合时的独特作用表明了需要进一步研究的特定相互作用机制.
相关概念视频
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
617
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
617
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.2K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.2K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
4.5K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
4.5K
Classification of Skeletal Muscle Relaxants
3.0K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
3.0K


